Clinical Trials Browser

Completed × INDUSTRY × ostarine × Clear all

NCT02463032 2020-12-09

Efficacy and Safety of GTx-024 in Patients With Estrogen Receptor (ER)+/Androgen Receptor (AR)+ Breast Cancer

Phase 2 Completed

136 enrolled 14 charts

ER+ and AR+ Breast Cancer

NCT01355497 2020-11-09

Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC) on First Line Platinum

Phase 3 Completed

330 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Muscular Atrophy

NCT01355484 2016-03-03

Phase III Study of the Effect of GTx-024 on Muscle Wasting in Patients With Non-Small Cell Lung Cancer (NSCLC)

Phase 3 Completed

321 enrolled 7 charts

Carcinoma, Non-Small-Cell Lung, Muscular Atrophy

NCT00467844 2014-07-11

Study of GTx-024 on Muscle Wasting (Cachexia) Cancer.

Phase 2 Completed

159 enrolled 11 charts

GastrointestinalLymphoidThoracic

Cachexia, Carcinoma, Non-Small-Cell Lung, Lymphoma, Non-Hodgkin, Muscular Atrophy, Colorectal Neoplasms